Association of polymorphisms in the cytochrome P450 (CYP) 2C19 and 2C18 genes in Japanese epileptic patients

Pharmacogenetics

Volumn 8, Issue 1, 1998, Pages 87-90

  Mamiya, Koshuke ^a   Ieiri, Ichiro ^a   Miyahara, Sayaka ^a   Imai, Jan ^a   Furuumi, Hiroyasu ^a   Fukumaki, Yasuyuki ^a   Ninomiya, Hideaki ^a   Tashiro, Nobutada ^a   Yamada, Hiroaki ^b   Higuchi, Shun ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

CYP2C18; CYP2C19; Genetic link; Polymorphism

Indexed keywords

CYTOCHROME P450; DIAZEPAM; IMIPRAMINE; OMEPRAZOLE; PROGUANIL; WARFARIN;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG METABOLISM; EPILEPSY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MUTATION; PHENOTYPE; PRIORITY JOURNAL; RAT;

ADULT; ARYL HYDROCARBON HYDROXYLASES; BASE SEQUENCE; CYTOCHROME P-450 ENZYME SYSTEM; DNA PRIMERS; EPILEPSY; GENOTYPE; HUMANS; JAPAN; MIXED FUNCTION OXYGENASES; PHARMACEUTICAL PREPARATIONS; POINT MUTATION; POLYMORPHISM, GENETIC; RESTRICTION MAPPING;

EID: 15644377076     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199802000-00012     Document Type: Article

References (17)

1. Bajpai M, Roscos LK, Shen DD, Levy RH. Roles of cytochrome P450 2C19 in the stereoselective metabolism of phenytoin to its major metabolite. Drug Metab Dispos 1996; 24, 1401-1403.
2. Daly AK, Brockmoller J, Broly F, Eichembaum M, Evans WE, Gonzalez FJ, Huang JD, Idle JR, Ingelman-Sundberg M, Ishizaki T. Nomenclature for human CYP2DT alleles. Pharmacogenetics 1996; 6, 193-201.
3. de Morais SMF, Schwekl H, Blaisdell J, Goldstein JA. Gene structure and upstream regulatory regions of CYP2C9 and CYP2C18. Biochem Biophys Res Commun 1993; 194, 194-201.
4. de Morais SMF, Wilkinson GR, Blaisdell J, Nakamura K, Meyer UA, Goldstein JA. The major genetic defect responsible for the polymorphism of S-mephenytoin in humans. J Biol Chem 1994a; 269, 15419-15422.
5. de Morais SMF, Wilkinson GR, Blaisdell J, Meyer UA, Nakamura K, Goldstein JA. Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese. Mol Pharmacol 1994b; 46, 594-598.
6. Goldstein JA, de Morais SMF. Biochemistry and molecular biology of the human CYP2C subfamily. Pharmacogenetics 1994a; 4, 285-299.
7. Goldstein JA, Faletto MB, Romkes-Sparks M, Sullivan T, Kitareewan S, Raucy JL, Lasker JM, Ghanayem BI. Evidence that CYP2C19 is the major (S)-mephenytoin 4′-hydroxylase in human. Biochemistry 1994b; 33, 1743-1752.
8. Gray IC, Nobile C, Muresu R, Ford S, Spurr NK. A 2.4-megabase physical map spanning the CYP2C gene cluster on chromosome 10q24. Genomics 1995; 28, 328-332.
9. Ieiri I, Kubota T, Urae A, Kimura M, Wada Y, Mamiya K, Yoshioka S, Irie S, Amamoto T, Nakamura K et al. Pharmacokinetics of omeprazole (a substrate of CYP2C19) and comparison with two mutant alleles. CYP2C19m1 in exon 5 and CYP2C19m2 in exon 4, in Japanese subjects. Clin Pharmacol Ther 1996; 59, 647-653.
10. mdiazepam N-demethylases. Drug Metab Dispos 1997; 25, 133-139.
11. Karam WG, Goldstein JA, Lasker JM, Ghanayem BI. Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes. Drug Metab Dispos 1996; 24, 1081-1087.
12. Kimura M, Ieiri I, Mamiya K, Urae A, Higuchi S. Genetic polymorphism of cytochrome P450s. CYP2C19 and CYP2C9, in a Japanese population. Ther Drug Monit; in press.
13. Komai K, Sumida K, Kaneko H, Nakatsuka I. Identification of a new non-functional CYP2C18 allele in Japanese: substitution of T204 to A in exon 2 generates a premature stop codon. Pharmacogenetics 1996; 6, 117-119.
14. Krecic ME, Shepard DR, Chang TH, Collins J, Gerber N. Stereoselective metabolism of phenytoin by hepatic microsomes and human CYP2C9 and CYP2C18 expressed in yeast. ISSX Proc 1995; 8, 370.
15. Meehan RR, Gosdon JR, Rout D, Hastle ND, Friedberg T, Adesnik M, Buckland R, van Heyningen V, Fletcher J, Spurr NK et al. Human cytochrome P450 PB-1: A multigene family involved in mephenytoin and steroid oxidations that maps to human chromosome 10. Am J Hum Genet 1988; 42, 26-37.
16. Pichard L, Curi-Pedrosa R, Bonfils C, Jacqz-Aigrain E, Domergue J, Joyeux H, Cosme J, Guengerich P, Maurel P. Oxidative metabolism of lansoprazole by human liver cytochrome P450S. Mol Pharmacol 1995; 47, 410-418.
17. Tsuneoka Y, Matsuo Y, Okuyama E, Watanabe Y, Ichikawa Y. Genetic analysis of the cytochrome P-450IIC18 (CYP2C18) gene and a novel member of the CYP2C subfamily. FEBS Letters 1996; 384, 281-284.